Cisplatin ototoxicity affecting cochlear implant benefit

Michael S. Harris, Jaimie L. Gilbert, Kelly A. Lormore, Swapna A. Musunuru, Michael H. Fritsch

Research output: Contribution to journalArticle

5 Scopus citations


Objective: Report a case of loss of cochlear implant benefit after cisplatin therapy to treat osteosarcoma. Examine the implications for the loci of cisplatin-associated cochleotoxicity. Study Design: Retrospective case review. Setting: Tertiary referral center. Patients: Single case study. Intervention(s): None. Main Outcome Measure(s): Cochlear implant programming levels. Results: Increase in cochlear implant programming T- and C-levels after cisplatin therapy. Conclusion: Cisplatin therapy likely affects spiral ganglion cells. It seems that auditory cells other than outer hair cells in the organ of Corti are affected by cisplatin because the hearing sensitivity of this patient with nonfunctioning outer hair cells declined after receiving chemotherapy. Implications of these findings are discussed.

Original languageEnglish (US)
Pages (from-to)969-972
Number of pages4
JournalOtology and Neurotology
Issue number6
StatePublished - Aug 1 2011


  • Cisplatin
  • Cochlear implant
  • Ototoxicity
  • Spiral ganglion cells

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Clinical Neurology
  • Sensory Systems
  • Medicine(all)

Fingerprint Dive into the research topics of 'Cisplatin ototoxicity affecting cochlear implant benefit'. Together they form a unique fingerprint.

  • Cite this

    Harris, M. S., Gilbert, J. L., Lormore, K. A., Musunuru, S. A., & Fritsch, M. H. (2011). Cisplatin ototoxicity affecting cochlear implant benefit. Otology and Neurotology, 32(6), 969-972.